Affibody® (affibody) ligands that are specific for the extracellular domain of human epidermal
growth factor receptor 2 (HER2/neu) have been selected by phage display technology from …

In vivo diagnosis with cancer-specific targeting agents that have optimal characteristics for
imaging is an important development in treatment planning for cancer patients. …

The 185 kDa transmembrane glycoprotein human epidermal growth factor receptor 2 (HER-2)
(p185/neu, c-ErbB-2) is overexpressed in breast and ovarian cancers. Overexpression in …

Purpose Targeted delivery of radionuclides for diagnostic and therapeutic applications has
until recently largely been limited to receptor ligands, antibodies and antibody-derived …

Objective Internet-based testing for Chlamydia trachomatis (CT) with self-sampling at home
has gradually been implemented in Sweden since 2006 as a free-of-charge service within …

Recombinant NcSRS2, a major immunodominant surface antigen of the intracellular
protozoan parasite Neospora caninum, was used as a model antigen to compare the …

Finding an appropriate adjuvant for human vaccination is crucial. HSPs have been shown
to act as adjuvants when coadministered with peptide antigens or given as fusion proteins. …

The coccidian parasite Neospora caninum is an intracellular protozoan, causing abortion in
cattle in many countries around the world. In this study, the protective potential of the major N…

To evaluate the possibility of generating novel proteins binding to highly glycosylated viral
proteins, affibody ligands were selected by bacteriophage display technology to the HIV‐1 …

We have previously reported strategies for Escherichia coli production of recombinant
immunogens fused to hydrophobic peptides or lipid tags to improve their capacity to be …